My Profile
Agnes Crane
Making a market in
Ideas
See all posts
Sun 29 Nov 2009 | 3:09 EST
You are here:
Home
>
Business & Finance
>
Stocks
> Officers and Directors
Home
Business & Finance
Markets
Deals
Small Business
Green Business
Industries
Industry Summits
Stocks
Advanced Stock Search
Overview
Option Quote
Chart
Officers and Directors
Key Developments
Company News
Press Releases
Financial Highlights
Ratios
Financial Statements
Performance
Insider Trading
Institutional Holders
Estimates
Recommendations
Analyst Research
Funds
ETFs
Currencies
Commodities
Options
Economy
Bonds
Analyst Research
Portfolio
News
Do More With Reuters
RSS
Widgets
Mobile
Podcasts
Newsletters
Your View
Make Reuters My Homepage
Partner Services
CareerBuilder
Affiliate Network
Professional Products
Support (Customer Zone)
Reuters Media
Financial Products
About Thomson Reuters
Officers and Directors For Isis Pharmaceuticals, Inc.
Isis Pharmaceuticals, Inc. (ISIS.O) (Consolidated Issue listed on NASDAQ Global Market)
sector:
Healthcare
.
industry:
Biotechnology
ยท
View
ISIS
on other exchanges
As of 27 Nov 2009
11.00
USD
Price Change
-0.19
Percent Change
-1.70%
Analyst Recommendations
Research Another Stock:
Symbol Look-up
Independent Research
|
Broker Research
Summary
Biographies
Basic Compensation
Options Compensation
Name
Age
Since
Current Position
Geary, Richard
51
2008
Senior Vice President - Development
Bennett, C. Frank
52
2006
Senior Vice President - Antisense Research
Wender, Joseph
64
1994
Director
Reed, John
50
2002
Director
Berthelsen, Spencer
57
2002
Director
Muto, Frederick
55
2001
Director
DiMarchi, Richard
56
2004
Director
Klein, Joseph
48
2005
Director
Parshall, B. Lynne
54
2007
Chief Financial Officer, Chief Operating Officer, Secretary, Director
Crooke, Stanley
64
1991
Chairman of the Board, President, Chief Executive Officer
Find out more about ISIS.O
Insider Trading